Marah Alzubi

MD || JU Graduate

[Marah Alzubi @MarahAlzubi01]

Honored to have received the Young Investigator Scholarship (YIP) from @SocietyofHemOnc 2024 and present my poster on young-onset multiple myeloma in Jordan vs the US! Grateful for the opportunity. #SOHO2024 #YoungInvestigator #MedTwitter

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Check our recent paper @BloodCancerJnl @UAMSMyeloma @utswcancer #mmsm
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients

➡️n=177
➡️CMV reactivation occurs in ~22% of teclistamab-treated myeloma patients
➡️90% are asymptomatic, no end-organ damage, and no survival impact.
▶️Key risk factor: prior CMV reactivation (3x increased odds)
Read full article: https://t.co/ww7CZYZIry
@asis_shr

[Marah Alzubi @MarahAlzubi01]

@Yazan_Imad_01 Congrats Yazan! Well deserved

[Marah Alzubi @MarahAlzubi01]

@NourAlnobani98 Congratulations!!

[Marah Alzubi @MarahAlzubi01]

@Nour_MMustafa Mashallah congratulations!!! Well done

[Marah Alzubi @MarahAlzubi01]

Chat GPT or Gemini?
Neither. Open evidence for the win. Hands down best AI tool for any medical student/physician.
#openevidence #ArtificialIntelligence

[Marah Alzubi @MarahAlzubi01]

@lafi_esra Your support means the world Esra’a❤️

[Marah Alzubi @MarahAlzubi01]

Starting 2026 with a publication I’m proud to share.

Our work on peripheral blood immune profiling & response to BCMA CAR-T in relapsed/refractory multiple myeloma is now published in Blood Cancer Journal.

#MultipleMyeloma #MedTwitter #Immunotherapy #Hematology #ResearchTwitter

[Marah Alzubi @MarahAlzubi01]

Link: https://t.co/dRgbv3S621

[Marah Alzubi @MarahAlzubi01]

@OsamaYo81168721 So proud. Congrats!!!

[Marah Alzubi @MarahAlzubi01]

@zainaajalil Mashallah congratulations 🎊

[Marah Alzubi @MarahAlzubi01]

@Yazan_Imad_01 Best of luck Dr. Yazan 👏🏻👏🏻

[Marah Alzubi @MarahAlzubi01]

link: https://t.co/unk8fkHkTd

[Marah Alzubi @MarahAlzubi01]

A dream came true. Thrilled to share our new publication in Blood Global Hematology: “Real-World Outcomes of Multiple Myeloma in a Resource-Constrained Setting: A 14-Year Experience from Jordan.”
Proud to have collaborated with such inspiring mentors on this important work.

[Samer Al Hadidi, MD,MS,FACP @HadidiSamer]

Real-World Outcomes of Multiple Myeloma in a Resource-Constrained Setting: A 14-Year Experience from a Tertiary Cancer Center in Jordan 🇯🇴#mmsm @BloodPortfolio published in Blood Global Hematology and led by @ZaidAR_MD and Dr Abeer Yaseen @KHCFKHCC

➡️ https://t.co/2jnAVw8CuY

Despite limited access to novel and maintenance therapies, auto transplant resulted in improvement in pts outcomes

[Marah Alzubi @MarahAlzubi01]

@Nour_mmaher19 Congrats Nour❤️

[Marah Alzubi @MarahAlzubi01]

@MuntaserZy Congrats Dr Muntaser !!

[مرح🌻 @ItsMarzbarz]

Guys I’m a doctor

[Marah Alzubi @MarahAlzubi01]

@MuntaserZy Well done Muntaser👏🏻 if anyone deserves this moment it’s definitely you, very proud !!

[Marah Alzubi @MarahAlzubi01]

@Yazan_Imad_01 Keep it up👏🏻

[Marah Alzubi @MarahAlzubi01]

@Yazan_Imad_01 Well done Yazan 👏🏻